Annual report pursuant to Section 13 and 15(d)

Sponsored Research and Clinical Trial Agreements (Tables)

v3.20.1
Sponsored Research and Clinical Trial Agreements (Tables)
12 Months Ended
Dec. 31, 2019
Sponsored Research and Clinical Trial Agreements  
Schedule of research and development for sponsored research and clinical trial agreements

For the years ended December 31, 2019 and 2018 Mustang recorded the following expense in research and development for sponsored research and clinical trial agreements:

 

 

 

 

 

 

 

 

 

 

($ in thousands)

 

 

 

For the Years Ended December 31, 

Institution

    

Program

 

2019

    

2018

City of Hope

 

CAR T development (multiple programs)

 

$

2,000

 

$

2,000

City of Hope

 

MB-102 (CD123 CAR T for AML)

 

 

1,202

 

 

835

City of Hope

 

MB-101 (IL13Rα2 CAR T for Glioblastoma)

 

 

876

 

 

1,056

City of Hope

 

Manufacturing License

 

 

457

 

 

458

St. Jude

 

MB-107 (XSCID)

 

 

777

 

 

 —

Fred Hutch

 

MB-106 (CD20 CAR T for GBM & Metastatic Breast Cancer to Brain)

 

 

762

 

 

1,301

Beth Israel Deaconess Medical Center

 

CRISPR (multiple programs)

 

 

69

 

 

69

 

 

Total

 

$

6,143

 

$

5,719